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BACKGROUND: Health services research has docu-
mented the magnitude of health care variations. Few
studies focus on provider level sources of variation in
clinical decision making-for example, which primary
care providers are likely to follow clinical guidelines,
with which types of patient.
OBJECTIVES: To estimate: (1) the extent of primary
care provider adherence to practice guidelines and the
unconfounded influence of (2) patient attributes and (3)
physician characteristics on adherence with clinical
practice guidelines.
DESIGN: In a factorial experiment, primary care provi-
ders were shown clinically authentic video vignettes
with actors portrayed different “patients” with identical
signs of coronary heart disease (CHD). Different types of
providers were asked how they would manage the
different “patients” with identical CHD symptoms.
Measures were taken to protect external validity.
RESULTS: Adherence to some guidelines is high (over
50% of physicians would follow a third of the recom-
mended actions), yet there is low adherence to many of
them (less than 20% would follow another third).
Female patients are less likely than males to receive 4
of 5 types of physical examination (p<.03); older
patients are less likely to be advised to stop smoking
(p<.03). Race and SES of patients had no effect on
provider adherence to guidelines. A physicians’ level of
experience (age) appears to be important with certain
patients.
CONCLUSIONS: Physician adherence with guidelines
varies with different types of “patient” and with the
length of clinical experience. With this evidence it is
possible to appropriately target interventions to reduce
health care variations by improving physician adher-
ence with clinical guidelines.
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S ocial and behavioral scientists have begun to identifydifferent nonmedical influences on provider clinical deci-
sion making. For a range of common medical problems,
clinical decision making appears to be influenced as much by
who the patient is (their age, race, or gender), which provider
they encounter, and the type of organizational setting in which
medical care is provided as it is by the signs and symptoms of
the problem itself 1–3. Some studies show that only about half
of those who utilize the health system actually receive the
recommended processes of medical care 4. Recently, attention
has turned to the quality of medical decisions–that is, the
extent to which specific providers adhere to appropriate
medical practice guidelines (test ordering, prescribing behav-
ior, life style recommendations, referrals, and patient follow-
up) for common medical problems presented by specific types
of patients 5. This paper focuses on specific sources of
variation in physician adherence to clinical guidelines: that
is, which primary care providers are likely to evidence appro-
priate clinical practice, with which types of patients? Evidence
on these specific sources of provider variation is required to
ensure that interventions to improve the quality of care and
reduce health variations are appropriately targeted. First, we
sought to identify the extent to which providers adhere to
clinical guidelines in their clinical decision making; second, we
examine the influence of patient and provider factors on
clinical decisions making. Is variation associated with specific
patients? Is it associated with particular providers?
METHODS
The objective of this research was to estimate the unconfounded
influence (either singly or in combination) of: (a) patient attributes
(age, gender, race, and socioeconomic status) and (b) provider
characteristics (physician gender and years of clinical experience)
on medical decision making when providers are presented
“patients” who show identical signs and symptoms strongly
suggestive of coronary heart disease (CHD) (a common medical
problem). We conducted a factorial experiment that permits
estimation of unconfounded main effects and interactions of any
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2 of the variables listed above. The experiment focused on a range
of clinical decisions as they relate to a case of CHD 6, 7. Research
methods are summarized below (see also McKinlay et al 2006, 8.
A version of the videotaped CHD condition (varying by age,
race, or gender) was shown to each of the physicians recruited
as subjects for the experiment. We recruited a total of 128
Massachusetts licensed, randomly sampled internists and
family physicians. We stratified subjects according to gender
and level of clinical experience, including eligible physicians
until each cell was complete. The “patient” (reluctantlymade the
appointment) presents with a complaint of “indigestion” and
features of chronic atypical chest pain. For the estimation of
main effects, a total sample of 128 physicians gives 80% power
to detect an absolute difference in means of 25%. For 2-way
interactions, it provides 80%power to detect an effect size of .25.
The effect size is a ratio of the variability of the hypothesized
means divided by the variability of the observations. For 2
means with a difference Δ, standard deviation of subjects s, the
effect size Δ/2s 9. Immediately after viewing the selected video
for the experiment, the experimental subjects completed a
semistructured interview. This interview included questions
concerning how they wouldmanage the case of CHD depicted in
the video in their everyday clinical practice, including theirmost
likely diagnoses, their certainty with respect to the diagnosis,
test ordering, prescriptions, lifestyle recommendations, and
what other information they might seek. Qualitative techniques
were employed to elicit the reasons why decisions were made.
Experimental Stimuli (Scenarios)
Professional actors and actresses were recruited and trained
(under experienced physician supervision) to realistically por-
tray a “patient” presenting to a primary care provider with the
signs and symptoms of CHD. Sixteen versions of the scenario
were videotaped, systematically varying the “patient’s” age (55
vs. 75 years to get some separation between the middle aged
and older patients), race (white vs. black), gender and socio-
economic status (lower vs. higher social class—a janitor vs. a
teacher). Potentially relevant nonverbal indicators were em-
bedded in the script, such as the “Levine fist.” Each videotaped
encounter simulated an initial interview with either an inter-
nist or family practitioner and was of 7–8 minutes in duration,
reflecting the average length of a consultation (face time) with a
primary care physician (not including a physical exam 10).
CHD was selected because: (a) it is among the most common
and costly problems presented by older patients to primary
care providers 11; (b) it is a relatively well-defined organic
medical condition; and (c) it can result in a range of possible
diagnostic, therapeutic, and life style actions. A script for the
case of CHD was developed from tape-recorded role-playing
sessions with experienced, clinically active advisors. “Patients”
in the CHD vignette presented with symptoms suggestive,
although not pathophenomic, of CHD (including, for example,
heartburn, indigestion unrelieved with antacids, new subster-
nal discomfort, which is exertional and resolves after several
minutes rest, pain in the back between the shoulder blades,
stress, and elevated blood pressure).
Experimental Subjects (Physicians)
To be eligible for selection, an equal number of male and female
physicians had to: (a) be internists or family practitioners; (b)
have ≤12 years clinical experience (graduated between 1989
and 1996) or ≥22 years experience (graduated between 1965
and 1979) to get clear separation by level of experience; (c) be
trained at an accredited medical school in the US; and (d) be
currently providing clinical care at least half time. Eligible
physicians were randomly sampled from throughout Massa-
chusetts to fill 4 design cells (gender by level of experience).
Screening telephone calls were conducted to identify eligible
subjects and an hour-long, in-person interview was scheduled
(at which time informed consent was obtained). Each physi-
cian subject was provided a modest stipend ($100) to partially
offset lost revenue and to tangibly acknowledge participation.
The response rate was 64.9%.
Assessing the Quality of Medical Care
Assessment of the quality of decision making requires some
gold standard against which physician behavior can be
compared. We originally planned to derive this standard from
2main sources: (a) official clinical guidelines promulgated by,
for example, AHRQ and AHA; and (b) the recommendations of
a respected group of local clinical peers as to what any
minimally competent provider should do when encountering
the videotaped “patient.” This approach was designed to
accommodate the competing interests of different groups by
developing a consensus view triangulated from these 2 sources
on the most appropriate management of the presenting
“patients” on the videotape. Table 1 depicts considerable
divergence between the actions listed in the clinical guidelines
Table 1. The Concordance or Discordance Between 6 Boston Area




Quality of pain -
Duration of pain -
Provoking factors ∅
Reliving factors -


















Short acting nitrates √
Lifestyle recommendations
Diet or weight -
Exercise -
Smoking -
∅=3 physicians in agreement with guidelines
√=>3 physicians in agreement with guidelines
= <3 physicians in agreement with guidelines
Sources: Gibbons RJ, et al. 12 and Gibbons RJ, et al. 13
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and the recommendations made by clinically active peers.
Furthermore, there was little consensus among the clinical
peers as a group about the recommended action for the clinical
case. This divergence may partly explain the fact that when
asked whether their knowledge of guidelines contributed to
their decisions with respect to the “patient” in the videotape,
75% of the physician subjects, said “no”: There were no
significant differences in the use of guidelines depending on
physician gender (p=1.0) level of experience (p=.69), or their
interaction (p=.69). For the purposes of this paper, clinical
guidelines developed by ACC/AHA/ACP-ASIM (Guidelines for
the Management of Patients with Chronic Stable Angina 12, 13
for CHD were used as 1 useful gold standard (recognizing there
are others) against which physician decision making could be
assessed. The clinical actions recommended in these guidelines
were grouped into 5 categories, following the logical order of the
encounter: information seeking, physical examination, test
ordering, drug prescriptions, and life style recommendations.
Whereas chest x-ray is not required for all patients with CHD,
the guidelines strongly recommend it if there is evidence of
congestive heart failure, valvular heart disease, pericardial
disease, aortic dissection, or pulmonary disease.
Validity of the Experimental Approach
With every study there is some trade off between internal and
external validity. The present experimental study has excellent
internal validity, but its external validity can be questioned.
Four precautionary steps were taken to enhance external
validity, that is, whether the responses subjects gave represent
the care they would truly provide. First, to achieve clinical
authenticity of the scenario, physicians provided expertise
during script development and were present during filming,
where professional actors played the patient roles. Second,
when physician subjects were asked how typical the “patient”
viewed on the videotape was compared with patients in their
everyday practice, 92% considered them very typical or
reasonably typical. Third, the doctors viewed the tapes in the
context of their practice day (not at a professional meeting, a
course update, or in their home). In other words, it was likely
they saw real patients before and after they viewed the
“patient” scenario. Fourth, the doctors were specifically
instructed to view the “patient” as 1 of their own patients and
to respond as they would in their own practice.
RESULTS
We present primarily main effects results. There were a
number of significant 2-way interactions, but there was no
consistent pattern. The significant 2-way interactions are
discussed below when they modify significant main effects.
Results from the experiment are divided into 3 main groups.
First, we examined the proportion of physicians who would
follow the clinical guidelines for the management of CHD.
Second, we focused on the influence of 4 patient attributes
(gender, age, race, SES) and their relation to guideline
adherence. Third, we examined the influence of 2 provider
characteristics (physician gender, age/years of clinical experi-
ence). Thus, our experimental approach permits unconfound-
ed estimation of 5 different influences on physician behavior.
1. The Extent of Guideline Adherence
Figure 1 summarizes the proportion of Massachusetts
primary care physicians randomly sampled by design cell
who would follow clinical guidelines when encountering
the “patient” presenting with symptoms of CHD. A high
percentage would obtain a medical history (83%), order an
ECG/EKG (88%), examine the heart (74%), lungs (76%),
and abdomen (78%), and order a stress test (75%).
Compared to our guidelines standard, many physicians
would obtain incomplete information on pain (duration
and relieving factors), would not examine peripheral
extremities and the neck, and would not order a glucose
test or chest x-ray. Only a small proportion (6%) would
recommend an increase in physical activity. Whereas there
is high adherence to some guideline proscriptions (over
50% of primary providers would follow a third of them)
there is low adherence to many of them (less than 20% of
providers would follow a third of actions) recommended in
the guidelines. There was high adherence (>50%)
concerning the acquisition of information regarding pro-
voking factors and patient history; the examination of the
heart, lungs and abdomen; ordering EGG, hemoglobin,
and stress tests; and making dietary recommendations.
There was lower adherence (<20%) regarding the acquisi-
tion of information regarding the duration of pain, factors
that relieve it, and family history; the examination of the
extremities and neck; ordering glucose tests and x-rays;
and making recommendations to increase exercise level.
2. Influence of Patient Attributes
The influence of the “patient’s” gender on CHD guideline
adherence is depicted in Fig. 2. Female patients are
significantly less likely to receive 4 of the 5 components
of the physical examination: cardiac (heart; 84% of men vs
64% of women), pulmonary (lungs) (87% vs 64%), periph-
eral vascular (extremities) (18% vs 6%), and vascular neck
exam (26% vs 9%). Whereas many of the patient gender
differences in CHD guideline adherence do not reach
statistical significance, there is general consistency in the
results. The female “patients” received less than males on
2/3 of the specific clinical actions suggested in the guide-
lines (16 of the 23 listed).
Figure 3 summarizes results concerning the effect of
“patient” age (55 vs 75 years) on CHD guideline adherence.
The only significant difference concerned the recommen-
dation that the “patient” stop smoking-younger “patients”
were twice as likely (40%) to receive such advice as older
“patients” (23%, p<.04).
No significant differences or consistent patterns were
evident with respect to either the race (White vs Black) or
socioeconomic status (lower vs higher) of the “patient” and
physician adherence to guidelines.
3. The influence of Physician Characteristics
Figure 4 summarizes the overall (main) effects of physician
level of experience as to whether they follow guidelines
when encountering a “patient” with CHD. The gender of
the physician in the study did not appear related to his or
her adherence to the CHD guidelines. A physician’s level of
clinical experience, however, did produce several signifi-
cant findings. Table 2 shows that older/more experienced
providers were more likely to inquire about factors pro-
voking chest pain (for older patients), to order a glucose
test (for male patients) and to prescribe short-acting
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nitrates (62.5% of more experienced physicians vs 21.9%
of less experienced physicians, p<.0001). There was a
consistent pattern (although results did not achieve
statistical significance) of younger/less experienced doc-
tors conducting all 5 components of the physical exami-
nation, whereas the older/more experienced physicians
were more likely to order all 6 of the tests listed.
DISCUSSION
In this experiment, we provided physicians with a standardized
clinical scenario to examine their clinical decision making, and
compared this against 1 recognized standard of clinical guide-
lines for the evaluation of possible CHD. We found that whereas
there was high physician adherence to some of the clinical
guidelines for management of CHD, many physicians would not
follow others—less than 50%would adhere to 2/3 of the specific
recommendations. Moreover, characteristics of both the pro-
vider and the patient appear to play a role in adherence to
guidelines. The gender of the “patient” appears to be influential:
female “patients” received fewer of the actions recommended by
clinical guidelines for the diagnostic evaluation of CHD. A
“patient’s” age significantly affected a physician’s recommen-
dation to quit smoking. An explanation for this may be found in
the reaction of a physician colleague who stated, “I understand
this result. I’ve got older patients and I’ve been going on for
years about their smoking. They’re never going to quit. I’ve
really tried and I’ve given up.” A physician’s years of clinical
experience were also associated with significant differences:
less experienced doctors conducted more components of the
physical examination, whereas more experienced physicians
were more likely to recommend diagnostic testing.
The use of clinical guidelines as the gold standard for
clinical care was chosen for several reasons: they are a)
thought to reflect a consensus opinion based upon the current
medical evidence (panels of experts from professional socie-
ties), and b) a useful standard because they include history of
symptoms, clinical examination, diagnostic testing, and life-
style and pharmacologic intervention recommendations. It is
noteworthy that several parts of the clinical history and
physical examination are inadequately addressed, as these
are inexpensive and provide potentially critical information to
elucidate the problem. The majority of physicians included the
two diagnostic tests directly related to diagnosis of CHD,
namely EKG and stress testing, whereas there was greater
variability on tests for related or alternative diagnoses, such as
glucose testing for undiagnosed diabetes, or chest x-ray for
alternative diagnosis.
Considering those guidelines directly concerned with diag-
nosing and treating CHD and unstable or new angina, we find
that providers generally follow the testing guidelines well, but
are less adherent to those pertaining to historical information,
and early treatments with aspirin, beta blockers or short-
Figure 1. The percentage of primary care physicians who follow clinical guidelines when encountering a “patient” with coronary heart
disease. X axis = percent of physicians who follow guidelines. Y axis = actions recommended by clinical guidelines.
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activating nitrates. Likewise, the general differences in eliciting
historic information suggests that these differences are impor-
tant and could account for some of the gender disparities
observed. Guidelines that relate to primary and secondary
prevention, or assessment of important comorbidities may be
considered less important at the first evaluation, and thus
their lower use by physicians is perhaps understandable.
Some of the variability from the guidelines may reflect timing
issues, where providers would postpone beta blocker therapy
until after EKG and exercise stress testing, when the extent of
disease and potential risk of unstable angina is understood.
However, the prescription of short-acting nitrates or aspirin are
recommended for their potential protection against cardiac
events, even in this case of “heartburn” where upper gastroin-
testinal pathology may account for symptoms. The lack of
exercise counseling could reflect caution until the diagnosis is
established, but the samewould not hold for the 2/3 of providers
who would not recommend smoking cessation.
Our findings corroborate and extend the work of others, and
indicate that even when there are evidence-based guidelines
for the management of a condition as common as suspected
CHD, some physicians’ use of guideline activities continues to
lag. This has been identified in other conditions as well. For
example, regular monitoring of blood sugar is considered
essential to the effective treatment of diabetes and prevent
complications 14. However, Saaddine and colleagues 15 found
that only 29% of diabetic patients reported having their blood
sugar tested during the previous year. Another study by
McGlynn and colleagues 4 found that 24% of diabetic patients
received 3 or more glycosylated hemoglobin tests over a 2-year
period. Grant and colleagues 5 found fewer than half of all
diabetics with elevated glycosylated hemoglobins had a change
in medication, and only 10% of patients with elevated blood
pressure readings had a change in management.
Our results show gender differences in the initial evaluation
of possible CHD in women. Prior literature suggests reduced
rates of revascularization, or delay in care for acute coronary
events in women compared to men, as an explanation for
higher morbidity and mortality for CHD in women 16–22.
However, our findings suggest that gender disparities in
evaluation may begin even earlier in the clinical history and
physical examination for CHD.
Our findings did not show a main or interaction effect by
physician gender. That is, female physicians did not provide
more guideline-based care to either male or female patients
than did their male counterparts. Similarly, we found no
differences based on patient race in recommendations for
guideline appropriate CHD care.
The findings based on physician experience are mixed.
Whereas more experienced providers ordered more diagnostic
Figure 2. The percentage of primary care physicians who follow clinical guidelines when encountering a “patient” with coronary heart
disease: patient gender. X axis = percent of physicians who follow guidelines. Y axis = actions recommended by clinical guidelines. Red bars =
female. Blue bars = male.
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testing when the “patient” was older, their less experienced
counterparts conducted more thorough physical examina-
tions. The reduced behavioral counsel to older patients in the
vignette may reflect a bias that older patients are less likely to
adopt smoking cessation and other behavioral change. How-
ever, some evidence suggests that older patients are as or more
likely to adopt change 23.
Limitations
Several limitations of this study should be noted. First,
whereas the rigorous experimental design permits excellent
internal validity, external validity remains a threat. Four
precautionary steps were taken to hopefully minimize this
threat (physicians were involved in script development; study
subjects [physicians] were specifically asked how typical the
“patient” was compared with patients in everyday practice;
subjects viewed the tapes in the context of their practice day;
subjects were specifically instructed to view the “patient” as 1
of their own patients). Second, the response rate of 64.9&
(while high for a study of US physicians in the present climate)
means over a third of those eligible and selected did not agree
to participate. This is an unavoidable consequence of the
decision to randomly sample in an attempt to increase the
generalizability (external validity) of the research findings.
Third, the level of adherence to guidelines may depend on
which guidelines are selected as the gold standard. The
guidelines used in this research were recommended by clinical
colleagues as promulgated by a reputable professional organi-
zation and considered to have wide visibility among providers.
They are clearly only 1 set among many different guidelines
developed by numerous groups. Future research could inves-
tigate whether any variability in physician adherence is
guideline specific.
Implications
The implications of this study rest on the assumption that
physicians need to adopt and adhere to evidence-based
guidelines in their everyday practice. Evidence-based disease
management strategies, including early use of aspirin and
short-acting nitrates, cannot reach their full potential if not
incorporated into clinical care. The widely reported gender
inequalities in coronary heart disease are unlikely to be
reduced if improvements in the illness behavior of women
(personal risk assessment, symptom recognition, and earlier
help-seeking) are not matched by appropriate diagnoses, test
ordering, and lifestyle recommendations by providers 24. The
Figure 3. The percentage of primary care physicians who follow clinical guidelines when encountering a “patient” with coronary heart
disease: patient age. X axis = percent of physicians who follow guidelines. Y axis = actions recommended by clinical guidelines. Red bars =
55 years old. Blue bars = 75 years old.
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question is how to ensure the incorporation of clinical guide-
lines into everyday practice: that is, how to institutionally
support and reimburse physicians’ adherence to their own, or
their colleagues’ own, recommendations (possibly pay-for-
performance).
Whereas there is considerable literature addressing patient
barriers to adherence to treatment recommendations, less is
written on the barriers in clinical practice to physician
adherence to recommendations. Some authors cite inadequate
professional training 25, especially the limitations of training of
primary care providers to address so many complex medical
conditions. Others cite reimbursement policies that reward
procedures over evaluation and management. Other barriers
to adherence to guidelines include provider concerns about
“cookbook medicine”, perceived regulatory intrusion into prac-
tice and unwillingness to buy into the concept of management
guidelines. Other barriers may be a lack of systems support,
such as electronic medical records, which incorporate guide-
line management recommendations to ensure uniformity in
care; or lack of patient participation in decision support 26.
Lastly, the number of guidelines propagated and the lack of
concurrence among them make it difficult for providers to find
a clear consensus on the best management practices 27.
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Variable Patient Age (years) Less More
Information Seeking 75 34.4 71.9 .0452
Provoking factors 55 43.8 46.9
Patient Gender
Test Ordering Male 0.0 34.4 .0497
Glucose Female 9.4 18.8
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